{
  "id": "d5ccd86077ae1e90",
  "title": "Cocrystal Pharma , Inc . Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI - 988 for Prevention and Treatment of Norovirus",
  "description": "20251218T183000Z",
  "content": "",
  "source": "marketscreener.com",
  "source_url": "https://www.marketscreener.com/news/cocrystal-pharma-inc-receives-irb-approval-from-emory-university-school-of-medicine-for-phase-1b-h-ce7d50dcd189f42d",
  "published_at": "20251218T183000Z",
  "fetched_at": "2025-12-19T00:23:08.544189+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "",
  "raw_data": {
    "url": "https://www.marketscreener.com/news/cocrystal-pharma-inc-receives-irb-approval-from-emory-university-school-of-medicine-for-phase-1b-h-ce7d50dcd189f42d",
    "url_mobile": "",
    "title": "Cocrystal Pharma , Inc . Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI - 988 for Prevention and Treatment of Norovirus",
    "seendate": "20251218T183000Z",
    "socialimage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
    "domain": "marketscreener.com",
    "language": "English",
    "sourcecountry": ""
  }
}